Literature DB >> 3156649

Interference of sodium with [3H]-nitrendipine binding to cardiac membranes.

J Schwartz, J Velly.   

Abstract

Interference of sodium with [3H]-nitrendipine binding was studied on membrane homogenates from guinea-pig skeletal muscle, cerebral cortex and left cardiac ventricle. [3H]-nitrendipine binding on homogenates from cerebral cortex and skeletal muscle was unaffected by Na+ (35 and 140 mEql(-1]. On the other hand, for the myocardial receptors, addition of Na+ resulted in an increase in IC50 of nitrendipine. Simultaneously, for the myocardial preparations, saturation curves showed a decrease in [3H]-nitrendipine affinity and an increase in the number of binding sites.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3156649      PMCID: PMC1987275          DOI: 10.1111/j.1476-5381.1985.tb12935.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  17 in total

Review 1.  Control of cardiac contractility at the cellular level.

Authors:  R A Chapman
Journal:  Am J Physiol       Date:  1983-10

2.  Two configurations of a channel-forming membrane protein.

Authors:  P N Unwin; P D Ennis
Journal:  Nature       Date:  1984 Feb 16-22       Impact factor: 49.962

3.  Binding of the calcium channel blocker nitrendipine to its receptor in purified sarcolemma from canine cardiac ventricle.

Authors:  J G Sarmiento; R A Janis; R A Colvin; D J Triggle; A M Katz
Journal:  J Mol Cell Cardiol       Date:  1983-02       Impact factor: 5.000

4.  Purification of the putative calcium channel from skeletal muscle with the aid of [3H]-nimodipine binding.

Authors:  H Glossmann; D R Ferry; C B Boschek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-06       Impact factor: 3.000

5.  A hypothesis linking intracellular sodium, membrane receptors, and hypertension.

Authors:  P A Insel; H J Motulsky
Journal:  Life Sci       Date:  1984-03-12       Impact factor: 5.037

6.  Specific calcium antagonist binding sites in brain.

Authors:  P J Marangos; J Patel; C Miller; A M Martino
Journal:  Life Sci       Date:  1982-10-11       Impact factor: 5.037

7.  Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110.

Authors:  D R Ferry; A Goll; H Glossmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-07       Impact factor: 3.000

Review 8.  "Calcium antagonists": a class of drugs with a bright future. Part I. Cellular calcium homeostasis and calcium as a coupling messenger.

Authors:  I Cavero; M Spedding
Journal:  Life Sci       Date:  1983-12-26       Impact factor: 5.037

9.  Binding of [3H]nimodipine to cardiac and smooth muscle membranes.

Authors:  R A Janis; S C Maurer; J G Sarmiento; G T Bolger; D J Triggle
Journal:  Eur J Pharmacol       Date:  1982-08-27       Impact factor: 4.432

10.  [3H]nitrendipine receptors in skeletal muscle.

Authors:  M Fosset; E Jaimovich; E Delpont; M Lazdunski
Journal:  J Biol Chem       Date:  1983-05-25       Impact factor: 5.157

View more
  2 in total

1.  Novel interactions of cations with dihydropyridine calcium antagonist binding sites in brain.

Authors:  G T Bolger; P Skolnick
Journal:  Br J Pharmacol       Date:  1986-08       Impact factor: 8.739

2.  High and concentration-proportional accumulation of [3H]-nitrendipine by intact cardiac tissue.

Authors:  H Lüllmann; K Mohr
Journal:  Br J Pharmacol       Date:  1987-03       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.